Research and Markets (http://www.researchandmarkets.com/research/9m68sz/united_states) has announced the addition of the "United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020" report to their offering.

Liquid Biopsy Tests are emerging as a viable alternative to traditional methods for cancer screening. A liquid biopsy is a new type of blood test that has the potential to transform cancer treatment. Using this methodology, physicians avoid the traditional surgical and needle biopsies they use to determine the existence of cancer in patients. In United States Liquid Biopsy market; Screening Test is likely to capture major chunk of the market compared to Monitoring Market. It is anticipated that Liquid Biopsy Testing will be more helpful for monitoring cancer treatment and status after diagnosis than in screening for a cancer that may be years or even decades in the making and not otherwise detectable.

United States - Liquid Biopsy Potential Screening Market Analysis: In the United States liquid biopsy screening market, prostate cancer is the most popular segment. Lung cancer liquid biopsy screening stands at the last spot.

United States - Liquid Biopsy Potential Treatment Monitoring Market Analysis: In the United States liquid biopsy treatment monitoring market, breast cancer is the leading segment. Liver cancer stands at the fifth spot.

The report titled United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020 provides a comprehensive assessment of the fast-evolving, high-growth of Liquid Biopsy Market. This 79 page report with 41 Figures analyses the United States Liquid Biopsy Test Market and Volume by 5 Top Cancer Segment, Recent developments, Major Deals along with the driving factors and challenges for Liquid Biopsy Market.

The United States Liquid Biopsy Potential Market has been analyzed from two view points

1. United States Liquid Biopsy Potential Screening Market & Test Volume (2015 - 2020)

The Top 5 Cancer Segments covered are:

1. Lung Cancer

2. Breast Cancer

3. Colorectal Cancer

4. Prostate Cancer

5. Liver Cancer

2. United States Liquid Biopsy Potential Treatment Monitoring Market & Test Volume (2015 - 2020)

The Top 6 Cancer Segments covered are:

1. Lung Cancer

2. Breast Cancer

3. Colorectal Cancer

4. Prostate Cancer

5. Liver Cancer

6. Other Cancers

Key Topics Covered:

1. Executive Summary

2. United States - Liquid Biopsy Potential Market (2015 - 2020)

3. United States - Liquid Biopsy Potential Test Volume (2015 - 2020)

4. United States - Liquid Biopsy Potential Market Share (2015 - 2020)

5. United States - Liquid Biopsy Potential Market & Test Volume by Cancer Types (2015 - 2020)

6. United States - Liquid Biopsy Screening Potential Market & Test Volume by Cancer Types (2015 - 2020)

7. United States - Liquid Biopsy Treatment Monitoring Potential Market & Test Volume by Cancer Types (2015 - 2020)

8. Liquid Biopsy Market - Recent Development

9. Liquid Biopsy Market - Major Deals Analysis

10. Liquid Biopsy Market - Driving Factors

11. Liquid Biopsy Market - Challenges

For more information visit http://www.researchandmarkets.com/research/9m68sz/united_states